Goldman Sachs
LXRX icon

Goldman Sachs’s Lexicon Pharmaceuticals LXRX Stock Holding History

Goldman Sachs’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-100,000
Closed -$1.44M – 7109
2016
Q2 		$1.44M Sell
100,000
-150,000
-60% -$2.03M ﹤0.01% 3886
2016
Q1 		$2.99M Sell
250,000
-90,000
-26% -$944K ﹤0.01% 3140
2015
Q4 		$4.53M Buy
340,000
+157,700
+87% +$1.94M ﹤0.01% 2920
2015
Q3 		$1.96M Buy
+182,300
New +$1.99M ﹤0.01% 3813

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.26B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return